fluorodeoxyglucose f18 has been researched along with sulfur hexafluoride in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buck, AK; Ehrhardt, AR; Gabelmann, A; Haenle, MM; Kern, P; Kratzer, W; Mason, RA; Reuter, S | 1 |
Aiginger, C; Jöst, C; Prosch, H | 1 |
Benatsou, B; Bidault, S; Blay, JY; Chami, L; Chebil, M; Cioffi, A; Koscielny, S; Lassau, N; Le Cesne, A; Massard, C | 1 |
Essler, M; Heemann, U; Moog, P; Steubl, D; Stock, KF; Thürmel, K | 1 |
Gottstein, M; Graeter, T; Gruener, B; Haenle, MM; Kaltenbach, TE; Kratzer, W; Mason, RA; Oeztuerk, S | 1 |
Blagosklonov, O; Delabrousse, É; Jiang, Y; Liu, W; Qin, Y; Vuitton, DA; Wang, J; Wen, H; Zeng, H | 1 |
Adam, C; Boisgard, R; Canney, M; Carpentier, A; Chapelon, JY; Drier, A; François, C; Horodyckid, C; Huberfeld, G; Lafon, C; Prigent, A; Santin, MD; Vignot, A; Willer, JC | 1 |
Gvetadze, SR; Ilkaev, KD; Li, J; Lv, M; Sun, J; Xiong, P; Yang, X | 1 |
1 review(s) available for fluorodeoxyglucose f18 and sulfur hexafluoride
Article | Year |
---|---|
Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones.
Topics: Aftercare; Animals; Calcinosis; Contrast Media; Diagnostic Imaging; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inventions; Larva; Magnetic Resonance Imaging; Phospholipids; Positron-Emission Tomography; Radiopharmaceuticals; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2014 |
1 trial(s) available for fluorodeoxyglucose f18 and sulfur hexafluoride
Article | Year |
---|---|
Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Blood Volume; Contrast Media; Female; Fluorodeoxyglucose F18; France; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Molecular Targeted Therapy; Perfusion Imaging; Phospholipids; Piperidines; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Radiopharmaceuticals; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Platelet-Derived Growth Factor; Sulfur Hexafluoride; Thiazoles; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2012 |
6 other study(ies) available for fluorodeoxyglucose f18 and sulfur hexafluoride
Article | Year |
---|---|
Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Echinococcosis; Echinococcosis, Hepatic; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Male; Middle Aged; Phospholipids; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sulfur Hexafluoride; Tomography, Spiral Computed; Ultrasonography | 2007 |
[Isolated sarcoidosis of the spleen and liver as incidental ultrasound finding].
Topics: Abdominal Pain; Adult; Biopsy; Contrast Media; Diagnosis, Differential; Fatigue; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver; Liver Diseases; Phospholipids; Positron-Emission Tomography; Sarcoidosis; Spleen; Splenic Diseases; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Comparison of fluorine-18-deoxyglucose positron emission tomography/computed tomography and contrast-enhanced ultrasound in a patient with chronic periaortitis.
Topics: Aged; Contrast Media; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Male; Multimodal Imaging; Phospholipids; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Fibrosis; Sulfur Hexafluoride; Treatment Outcome; Ultrasonography, Interventional | 2013 |
Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Echinococcosis, Hepatic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Phospholipids; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Sulfur Hexafluoride; Tissue Survival; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2015 |
Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Topics: Administration, Intravenous; Animals; Blood-Brain Barrier; Capillary Permeability; Central Nervous System Agents; Electroencephalography; Equipment Design; Evoked Potentials, Somatosensory; Female; Fluorodeoxyglucose F18; Longitudinal Studies; Macaca fascicularis; Magnetic Resonance Imaging; Male; Microbubbles; Models, Animal; Papio anubis; Positron-Emission Tomography; Radiopharmaceuticals; Sulfur Hexafluoride; Ultrasonic Therapy | 2017 |
Contrast-enhanced ultrasound for diagnosis of an enlarged cervical lymph node in a patient with oropharyngeal cancer: a case report.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Oropharyngeal Neoplasms; Phospholipids; Positron-Emission Tomography; Radiopharmaceuticals; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2017 |